Hyperbaric oxygen to help prevent radiation-related lung injury
Part of Cancer, Injuries & trauma, Lungs & breathing, Skin clinical trials.
This trial tests whether breathing pure oxygen in a pressurized chamber (hyperbaric oxygen) can prevent lung inflammation caused by breast cancer radiation. It may help reduce the risk of radiation pneumonitis in certain breast cancer survivors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had breast cancer treated with surgery plus chemotherapy and radiation
- You do NOT currently have distant spread (metastases) or other new cancer areas
- You are 18–70 years old
- Before and after radiation, your chest CT showed no acute radiation lung injury
- You can do study visits, understand simple instructions, and have no confusion/mental illness issues
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether breathing in steroid medicine before and during radiation can lower how often and how badly “radiation lung inflammation” (radiation pneumonitis) happens in people with lung cancer. If you qualify, it may help protect your lungs while you receive radiation with chemotherapy or targeted therapy.
This study looks at how radiation therapy for breast cancer may affect your lungs over time. Researchers will measure lung function and see if problems develop, so they can better understand and protect patients.
This trial tests adding hyperbaric oxygen (breathing pure oxygen in a pressurized chamber) before standard chemotherapy for breast cancer. The goal is to see if it helps shrink the tumor more effectively before surgery.
This trial tests if adding hyperbaric oxygen (breathing pure oxygen in a high-pressure chamber) to standard pre-surgery treatment can help women with triple-negative or HER2-positive breast cancer. The goal is to see if it makes treatment work better and is safe.
This study tests adding hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) to standard neoadjuvant therapy (treatment before surgery) for people with hormone receptor positive breast cancer. The goal is to see if it helps shrink tumors more effectively while being safe.
This study tests whether breathing pure oxygen in a pressurized chamber (hyperbaric oxygen therapy) can help reduce nerve damage symptoms—like numbness, tingling, or pain in the hands and feet—caused by the chemotherapy drug paclitaxel in people with breast cancer.
Hear when a new Radiation Pneumonitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.